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Abstract 
Endometriosis is a complex disease that affects 6-10% of women in their reproductive years 
and 20-50% of women with infertility. Genome-wide and candidate-gene association studies 
for endometriosis have identified ten independent risk loci, and of these, nine (rs7521902, 
rs13394619, rs4141819, rs6542095, rs1519761, rs7739264, rs12700667, rs1537377 and 
rs10859871) are polymorphic in European populations. Here, we investigate replication of 
the nine SNP loci in 998 laparoscopically- and histologically-confirmed endometriosis cases 
and 783 disease-free controls from Belgium. SNPs rs7521902, rs13394619 and rs6542095 
show nominally significant (P < 0.05) associations with endometriosis, while the directions 
of effect for seven SNPs are consistent with the original reports. Association of rs6542095 at 
the IL1A locus with "All" (P = 0.066) and "Grade_B" (P = 0.01) endometriosis is noteworthy 
because this is the first successful replication in an independent population. Meta-analysis 
with the published results yields genome-wide significant evidence for rs7521902, 
rs13394619, rs6542095, rs12700667, rs7739264 and rs1537377. Notably, three coding 
variants in GREB1 (near rs13394619) and CDKN2B-AS1 (near rs1537377) also showed 
nominally significant associations with endometriosis. Overall, this study provides important 
replication in a uniquely characterised independent population and indicates that the majority 
of the original genome-wide association findings are not due to chance alone. 
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Endometriosis is the most common cause of pelvic pain that affects 6-10% of women in their 
reproductive years (Treloar et al., 1999) and 20-50% of women with infertility (Gao et al., 
2006). It is primarily characterized by the presence of endometrium-like tissue in cavities 
other than the uterus. Besides severe pelvic pain, women with endometriosis may also suffer 
from heavy or irregular menstrual bleeding, pain during intercourse and exercise, infertility, 
lower abdominal and back pain, diarrhoea and/or constipation and chronic fatigue. 
Endometriosis has a complex aetiology, which results from an interplay of genetic and non-
genetic risk factors and has an estimated heritability of approximately 51% (Treloar et al., 
1999). 
 We and others have conducted genome-wide association (GWA) studies involving 
individuals of European and Japanese ancestries to identify genetic risk factors for 
endometriosis (Albertsen et al., 2013; Nyholt et al., 2012; Painter et al., 2011; Uno et al., 
2010). Results from the four GWA studies strongly associated nine independent single 
nucleotide polymorphism (SNP) loci with endometriosis providing genome-wide significant 
(P < 5 × 10-8) evidence in at least one study. These risk loci include: rs10965235 in the 
CDKN2BAS gene at 9p21.3, rs12700667 at 7p15.2, rs7521902 near WNT4 at 1p36.12, 
rs13391619 in the GREB1 at 2p25.1, rs10859871 near VEZT at 12q22, rs4141819 at 2p14, 
rs7739264 near ID4 at 6p22.3, rs1537377 near CDKN2B-AS1 at 9p21.3, and rs1519761 at 
2q23.3. The GREB1 signal was implicated in a meta-analysis of the European 
(QIMRHCS+OX) and Japanese (BBJ) GWA data after combining published results for 
rs1339416 from Adachi et al. (2010) (Adachi et al., 2010) - a small GWA study comprising 
696 endometriosis cases and 825 controls of Japanese descent. A recent follow-up study by 
ourselves further implicated GREB1 locus in endometriosis risk, with stronger association 
signals within the region (Fung J.N. et al., 2015). Three risk loci (rs4141819 at 2p14, 
rs7739264 near ID4 at 6p22.3 and rs1537377 near CDKN2B-AS1 at 9p21.3) were implicated 
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when analysis was conducted after excluding endometriosis cases with minimal or mild 
[revised American Fertility Society (rAFS) (American Society for Reproductive Medicine, 
1997) stage 1 or 2 disease] endometriosis (Nyholt et al., 2012). More recently, we conducted 
a candidate-gene association study (Sapkota et al., 2015) to investigate the potential role of 
the interleukin 1A (IL1A) variants reported by two small Japanese GWA studies for 
endometriosis (Adachi et al., 2010; Hata et al., 2013). The study results provided genome-
wide significant evidence for association of rs6542095 in the IL1A with endometriosis. Taken 
together, results suggest a total of ten independent SNP loci for endometriosis at genome-
wide significant level, and of these nine are polymorphic in populations of European 
ancestry.  
The three replication studies (Pagliardini et al., 2015; Pagliardini et al., 2013; 
Sundqvist et al., 2013) performed to date, have only replicated association of rs7521902 (P = 
5.6 × 10-3) (Pagliardini et al., 2013) and rs10859871 (P = 6.9 × 10-5) (Pagliardini et al., 2015) 
with endometriosis. Inherently hidden fine stratification among different populations of 
similar ancestry, which is often difficult to tease apart, power and possible variations in 
disease definition and/or classification may have contributed to these inconsistent results. 
Moreover, these replication studies have investigated only a fraction of the implicated SNP 
loci and hence additional replication studies are required to examine association of all the risk 
loci with endometriosis. 
Here, we extended our previous study (Sundqvist et al., 2013) to evaluate all nine 
implicated SNP loci for endometriosis that are polymorphic in populations of European 
ancestry, utilizing GWA data for surgically confirmed 998 endometriosis cases and 783 
disease-free controls from Belgium. Importantly, disease severity in the endometriosis cases 
have been prospectively graded using the rAFS classification system and hence are less likely 
to be misclassified as compared to the retrospective disease staging based on clinical records. 
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We also performed meta-analysis for the nine risk loci, after combining results from the 
current study with the relevant published results. Finally, we conducted GWA analysis of the 
observed data in the Belgian cohort to see if there were any novel loci associated with 
endometriosis risk identified in this sample. 
Materials and Methods 
Study participants 
Cases (n = 1,077) and controls (n = 900) included in this study were recruited at the Leuven 
University Hospital, Belgium during 1993 - 2012, who had undergone laparoscopy for 
subfertility with or without pain. Presence of endometriosis in cases was laparoscopically- 
and histologically-confirmed based on electronic medical file records. The disease severity in 
women with endometriosis was prospectively graded according to the rAFS classification 
system. Endometriosis cases had either minimal (stage I; n = 380), mild (stage II, n = 229), 
moderate (stage III, n = 174), severe (stage IV; n = 284) or unknown (n = 10) disease. 
Absence of endometriosis in controls was confirmed laparoscopically. Both cases and 
controls were Caucasian in origin. All the study participants provided written informed 
consent and the study was approved by the Commission of Medical Ethics of the Leuven 
University Hospital, Belgium and QIMR Berghofer Human Ethics Research Committee, 
Australia. 
DNA extraction and genotyping 
DNA was purified from EDTA-stabilized whole blood collected for routine molecular 
diagnostic tests at the Centre for Human Genetics of University Hospitals, Leuven, Belgium. 
Following manufacturer's protocol, DNA was purified using Chemagic DNA blood special 
kit (Chemagen MSM I, PerkinElmer chemagen Technologies GmbH, Baesweiler, Germany) 
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based on the specific binding of DNA to paramagnetic beads, and Auto Pure LS Puregene 
chemistry (Qiagen, Venlo, The Netherlands) based on salting-out extraction and a manual 
salting-out procedure (home-brew). The choice of the extraction method was based on the 
available amount of blood and on the type of required molecular diagnostic test. DNA 
concentration was measured using Victor (PerkinElmer, Massachussetts, USA). 
 Whole genome genotyping of the DNA samples was performed using the Illumina 
HumanCoreExome 12v1.1 array at the Molecular Epidemiology Laboratory, QIMR 
Berghofer Medical Research Institute, Brisbane, Australia, following manufacturer's standard 
protocol. For a quality control (QC) check, DNA concentrations of majority of the samples 
were re-measured on the BioTech Powerwave at the QIMR Molecular Epidemiology 
Laboratory, before genotyping. The Illumina HumanCoreExome genotyping arrays are the 
newer generations of Illumina GWA arrays, which consist of ~250,000 common tag SNPs 
('Core') and ~250,000 predominantly rare coding variants ('exome'). The exome variants in 
the Illumina HumanCoreExome were carefully selected based on exome sequencing data in 
~12,000 individuals.  
Genotype calling and QC 
Genotype data were called using a custom cluster file generated using ~2,000 good quality 
(<1% missing rate) samples and the GenCall algorithm within Illumina Genome Studio. Data 
were then further processed by zCall (Goldstein et al., 2012), a rare variant caller, to attempt 
to re-call missing genotypes. Following guidelines by the manufacturer and protocols 
developed for Exome chip data, quality control measures were applied to the Belgian GWA 
data. Briefly, samples with > 1% missing rates, outlying heterozygosity, non-European 
ancestries based on 1000 Genomes European populations, cryptic relatedness (pi-hat > 0.2) 
and gender discordances were excluded. Similarly, markers with poor separation of three 
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genotype clusters, excess heterozygosity, outlying mean theta and intensity values for 
heterozygote genotypes, > 1% missing rates, Hardy-Weinberg Equilibrium (HWE) P < 10-6 
in controls, and minor allele frequency (MAF) < 0.05% in cases and in controls were 
dropped. 
Association analysis 
Since rs1096523 in the CDKN2BAS gene at 9p21.3 is monomorphic in populations of 
European ancestry, we considered the remaining nine SNP loci (rs7521902, rs13394619, 
rs4141819, rs6542095, rs1519761, rs7739264, rs12700667, rs1537377 and rs10859871) for 
further analysis. To see if there were any novel association signals for endometriosis in the 
Belgian cohort, GWA analysis of the observed genotypes was performed using --assoc (for 
'core' SNPs) and --fisher (for 'exome' variants) commands in Plink for data including all 
endometriosis cases ("All") and controls. Considering the relatively greater genetic loading of 
moderate-to-severe (rAFS stage III/IV or "Grade_B") endometriosis compared to mild or 
minimal (rAFS stage I/II or "Grade_A") endometriosis (Nyholt et al., 2012; Painter et al., 
2011; Sapkota et al., 2015), additional analysis for "Grade_B" endometriosis cases versus 
controls was also performed. Strengths of association of SNPs with endometriosis are 
reported in terms of odds ratio (ORs) and confidence intervals (CIs). 
Imputation and Meta-analysis 
Of the nine SNPs, only six (rs7521902, rs13394619, rs4141819, rs6542095, rs7739264 and 
rs12700667) are assayed on Illumina HumanCoreExome 12v1.1 genotyping platform. 
Therefore, we imputed genotypes in chromosomes containing the nine SNP loci in the 
Belgian GWA data, using a reference panel of 1000 Genomes Project (March 2012 release). 
Imputation was carried out using SHAPEIT (Delaneau et al., 2012) and minimac programs 
(Li et al., 2009; Li et al., 2010) and following the two-step approach outlined in the online 
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Minimac: 1000 Genomes Imputation Cookbook 
(http://genome.sph.umich.edu/wiki/Minimac:_1000_Genomes_Imputation_Cookbook). 
Quality of the imputed genotypes was assessed by R2 metric, which estimates the squared 
correlation between true and imputed genotypes. Poorly imputed SNPs indicated by R2 < 0.3 
were excluded from the downstream analyses. Association analyses of imputed genotype 
dosage scores of the nine SNP loci were conducted using Plink for "All" and "Grade_B" 
endometriosis cases separately. 
After combining results of imputed dosage scores for the nine SNP loci from Belgian 
data with the published results from Nyholt et al. (2012) (Nyholt et al., 2012), Adachi et al. 
(2010) (Adachi et al., 2010), Albertsen et al. (2013) (Albertsen et al., 2013) and Sapkota et 
al. (2015) (Sapkota et al., 2015), we performed meta-analysis for "All" endometriosis cases 
and controls. A brief summary of the datasets used in this study is provided in Table 1. 
Results from  Nyholt et al. (2012) (Nyholt et al., 2012) included summary statistics of the 
rs7521902, rs13394619, rs4141819, rs7739264, rs12700667, rs1537377 and rs10859871 
obtained from the European (QIMRHCS+OX) and Japanese (BBJ) GWA data (Table 1). 
Similarly, we included results of the rs13394619 and rs6542095 from Adachi et al. (2010) 
(Adachi et al., 2010), obtained from combined analysis of 500K and 6.0 arrays in 696 cases 
and 825 controls of Japanese ancestry. Furthermore, results from Albertsen et al. (2013) 
(Albertsen et al., 2013) included summary statistics of the rs1519761 in their discovery and 
replication stages. Finally, we obtained imputed results of the rs6542095 in the QIMRHCS, 
OX and BBJ imputed data from Sapkota et al. (2015) (Sapkota et al., 2015). 
Initial meta-analysis was conducted using a fixed-effects (inverse variance-weighted) 
model implemented in the GWAMA program (Magi & Morris, 2010). Heterogeneity of 
allelic associations was examined using the Cochran's Q statistic Phet < 0.1 (Cochran, 1954), 
as well as the I2 index (Ioannidis et al., 2007), which indicates the proportion of variance 
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attributable to between-study heterogeneity. Meta-analysis of SNPs associated in fixed-
effects model withevidence of heterogeneity (P < 0.1) was carried out using the Han Eskin 
random-effects model (RE2) (Han & Eskin, 2011) implemented in the METASOFT program. 
In contrast to the conventional random-effects model, the RE2 model increases power under 
heterogeneity. Furthermore, additional meta-analysis for the nine SNP loci was also 
performed by restricting to "Grade_B" endometriosis cases (wherever available) versus 
controls.  
Results 
Following the QC steps, a total of 998 endometriosis cases and 783 disease-free controls with 
316,467 markers remained in the Belgian GWA data for downstream analysis. Of these, 
246,071 were 'core' SNPs whereas 70,396 were 'exome' variants. The GWA analysis of 
observed genotypes of the 316,467 markers in the Belgian GWA study alone did not produce 
any genome-wide significant hits in either "All" or "Grade_B" analysis with few suggestive 
(P < 1 × 10-5) associations (data not shown). All nine SNPs were accurately imputed with R2 
> 0.95. Furthermore, we also compared imputed genotypes (dosage scores) of the six SNP 
loci (rs7521902, rs13394619, rs4141819, rs6542095, rs7739264 and rs12700667) for 
endometriosis with the observed true genotypes available in the Belgian data. Genotype 
concordances (as measured by the Pearson's correlation coefficient) between two sets of 
genotypes for the six SNPs were > 0.99 (P < 2.2 × 10-16). 
 Association analysis of the dosage scores of the nine implicated SNP loci in the 
Belgian data provided further insights into associations of these SNPs with endometriosis. 
Risk alleles and their frequencies of all nine SNPs were similar to the ones reported in the 
original studies (Table 2) (Albertsen et al., 2013; Nyholt et al., 2012; Painter et al., 2011; 
Sapkota et al., 2015) and their associations were stronger with "Grade_B" than "All" 
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endometriosis. Furthermore, effect directions of seven out of nine tested SNPs in either "All" 
or "Grade_B" endometriosis were in line with the published results. Three SNPs showed 
statistically significant association with endometriosis in either "All" or "Grade_B" disease at 
a nominal P < 0.05. SNP rs7521902 showed borderline marginal association (OR = 1.13; P = 
0.12) with "All" endometriosis. As expected, its association was much stronger and 
statistically significant (OR = 1.30; P = 0.007) with "Grade_B" cases. A statistically 
significant association (OR = 1.14; P = 0.045) for rs13394619 was also observed for "All" 
endometriosis; however, the signal was slightly weaker (OR = 1.13; P = 0.164) in "Grade_B" 
cases. A borderline association (OR = 1.14; P = 0.06) with "All" endometriosis was observed 
for rs6542095, which was stronger and significant (OR = 1.26; P = 0.01) in "Grade_B" cases. 
 Meta-analysis including imputed data from Belgian cohort and the published results 
provide insights into SNP loci associated with endometriosis. Six SNP loci showed 
associations with either "All" or "Grade_B" endometriosis at genome-wide significance level 
(P < 5 × 10-8) and with similar directions of effect across all studies included in the analysis 
(Table 3). Of these, three SNPs were associated with both "All" and "Grade_B" 
endometriosis with a genome-wide significant evidence in the fixed-effects meta-analysis. 
These include: SNP rs7521902 near WNT4 ["All" (OR = 1.17; 95% CI = 1.11-1.23; P = 3.63 
× 10-8), "Grade_B" (OR = 1.25; 95% CI = 1.17-1.34; P = 1.72 × 10-10)], rs13394619 in 
GREB1 ["All" (OR = 1.15; 95% CI = 1.10-1.20; P = 9.13 × 10-9), "Grade_B" (OR = 1.17; 
95% CI = 1.11-1.24; P = 3.02 × 10-8)] and rs12700667 at 7p15.2 ["All" (OR = 1.19; 95% CI 
= 1.13-1.26; P = 7.10 × 10-10), "Grade_B" (OR = 1.29; 95% CI = 1.20-1.39; P = 1.47 × 10-
11)]. The IL1A SNP (rs6542095) was genome-wide significantly associated with only 
"Grade_B" (OR = 1.22; 95% CI = 1.14-1.30; P = 1.00 × 10-9) endometriosis in fixed-effects 
meta-analysis, but after appropriately modelling for between-study heterogeneity in "All" 
endometriosis (Phet = 0.007) in the RE2 model, the association reached genome-wide 
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significance (P = 3.35 × 10-8). Statistical significance of association of the rs6542095 with 
"Grade_B" endometriosis also became stronger (P = 4.90 × 10-10) in the RE2 model, after 
accounting for between-study heterogeneity (Phet = 0.01). A strong association between 
rs7739264 near ID4 and "All" endometriosis (P = 1.93 × 10-7) was observed, and the signal 
was further enriched in "Grade_B"  endometriosis (OR = 1.20; 95% CI = 1.12-1.27; P = 1.98 
× 10-8) achieving genome-wide significance. Similarly, near genome-wide significant 
evidence for association between rs1537377 near CDKN2B-AS1 and "Grade_B" 
endometriosis (OR = 1.19; 95% CI = 1.12-1.27; P = 9.27 × 10-8) was observed, which was 
genome-wide significant (P = 4.80 × 10-8) after modelling for borderline between-study 
heterogeneity (Phet = 0.10). However, the effect of rs1537377 in "All" endometriosis was in 
opposite direction to the published results (Table 2). 
 While the remaining three SNPs (rs4141819, rs1519761 and rs10859871) did not 
produce genome-wide significant evidence for association with either "All" or "Grade_B" 
endometriosis in fixed-effects meta-analysis, they still showed strong associations with the 
disease (P < 2.38  × 10-5). Nonetheless, the effects of rs4141819 and rs1519761 in both "All" 
and "Grade_B" endometriosis, and rs10859871 in "All" endometriosis were in opposite 
directions to the published results (Table 2). SNP rs4141819 showed between-study 
heterogeneity (Phet < 0.01) in both "All" and "Grade_B" endometriosis and after accounting 
for this heterogeneity in the RE2 model, association of rs4141819 with "Grade_B" disease 
became stronger with near genome-wide significant evidence (P = 3.63 × 10-7). Significant 
between-study heterogeneity for rs1519761 was also observed in both "All" and "Grade_B" 
endometriosis, but its association with the disease ["All" (P = 5.62 × 10-6), "Grade_B" (P = 
1.94 × 10-6)] slightly diluted in the RE2 model ["All" (P = 1.07 × 10-5), "Grade_B" (P = 7.99 
× 10-6)]. A near genome-wide significant association between rs10859871 near VEZT and 
"All" endometriosis (OR = 1.16; 95% CI = 1.09-1.22; P = 4.29 × 10-7) was observed, with 
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slightly larger effect size (OR = 1.17; 95% CI = 1.10-1.25) in "Grade_B" disease although 
statistical significance of the signal was weaker (P = 2.46 × 10-6). 
Discussion 
Endometriosis is a complex disease and studies have shown that genetic risk factors 
substantially contribute to risk of endometriosis. Genetic studies, especially the GWA studies 
for endometriosis have identified ten SNP loci, of which nine are polymorphic in the 
populations of European origin (Albertsen et al., 2013; Nyholt et al., 2012; Painter et al., 
2011; Sapkota et al., 2015). While much larger and well-powered GWA studies are needed to 
identify additional genetic risk factors involved in risk of endometriosis, replication studies 
are crucial to provide credibility that the initial genotype-phenotype associations are valid. 
Repeated observation of such associations in independent populations of similar ethnicity 
adds evidence that the associations are not due to chance alone. The previous two replication 
studies for endometriosis have investigated only a handful of the ten implicated SNP loci to 
date. Here, we report the most comprehensive replication study performed to date, in which 
we examine all nine implicated SNP risk loci for endometriosis that are polymorphic in 
populations of European ancestry, by utilizing GWA data in uniquely characterized 998 
endometriosis cases and 783 controls from Belgium.  
 The risk alleles and their frequencies for all the nine SNPs in the Belgian replication 
cohort were comparable to the original studies (Table 2) (Albertsen et al., 2013; Nyholt et al., 
2012; Painter et al., 2011; Sapkota et al., 2015). Moreover, direction of effects for seven of 
the nine SNPs for either "All" or "Grade_B" endometriosis were also consistent with the 
published results. Among these, we could successfully replicate associations of three SNPs 
(rs7521902, rs13394619 and rs6542095) with either "All" or "Grade_B" endometriosis at 
nominal P < 0.05, which is more often than by chance alone (P = 0.008; one-sided binomial 
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test). Significant association of rs6542095 at the IL1A locus with "All" (P = 0.066) and 
"Grade_B" (P = 0.01) endometriosis is noteworthy as this is the first successful replication in 
an independent population, providing further supporting evidence for a potential link between 
inflammation and endometriosis pathogenesis. More importantly, all the SNPs showed larger 
effect sizes with "Grade_B" than "All" endometriosis - an observation consistent with 
previous reports supporting greater genetic loading in moderate-to-severe disease (Nyholt et 
al., 2012; Painter et al., 2011; Sapkota et al., 2015).  
Our meta-analysis including results from the current replication study and the 
published results produced genome-wide significant evidence for six (rs7521902 near WNT4, 
rs13394619 in GREB1, rs6542095 in IL1A, rs7739264 near ID4, rs12700667 at 7p15.2 and 
rs1537377 near CDKN2B-AS1) of the nine implicated SNPs in either "All" or "Grade_B" 
endometriosis, after accounting for between-study heterogeneity using the RE2 model, 
wherever appropriate (Table 3). With the exception of rs1519761 at 2q23.3 reported by 
Albertsen et al. (2013), the other two SNP loci (rs4141819 at 2p14 and rs10859871 near 
VEZT) also showed near genome-wide significance for "Grade_B" endometriosis in the RE2 
model (P = 3.63 × 10-7) and for "All" endometriosis in the fixed-effects model (P = 4.29 × 
10-7), respectively. The association signal for rs1519761 was the weakest ["All" (P = 5.62 × 
10-6), "Grade_B" (P = 1.94 × 10-6)] amongst the nine risk loci and the signal was slightly 
diluted after accounting for observed between-study heterogeneity in the RE2 model ["All" 
(P = 1.07 × 10-5), "Grade_B" (P = 7.99 × 10-6)]. Association signal at this locus was also not 
replicated in a recent meta-analysis for endometriosis (Rahmioglu et al., 2014), suggesting 
further investigation is required to confirm a role for this locus in risk of endometriosis. 
In our multi-ethnic GWA meta-analysis that strongly associated seven risk loci with 
endometriosis, we found stronger associations at six loci (rs56318008 at 1p36.12, rs77294520 
at 2p25.1, rs2861694 at 2p14, rs6901079 at 6p22.3, rs7041895 at 9p21.3 and rs11107968 at 
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12q22), when we imputed genotypes in the region 2,500 kb upstream and downstream of the 
most significant genotyped SNP using the full reference panel from the 1000 Genomes 
Project Interim Phase 1 Haplotypes (2010-2011 data freeze). For the risk loci at 7p15.2, the 
genotyped SNP rs12700667 was the best signal. For the remaining six loci with stronger 
association signals ('best' SNPs) post-imputation than the genotyped SNP, we assessed for 
their replication in the Belgian cohort (Table 4). All six SNPs were accurately imputed in the 
current study with R2 > 0.85. Association results were consistent with that of the original 
genotyped SNPs as shown in Table 2, in particular for the SNPs rs56318008 at 1p36 and 
rs77294520 at 2p25.1 that showed nominally significant associations with "All" (P < 0.098) 
and "Grade_B" (P < 0.051), providing further supporting evidence for implication of these 
risk loci in endometriosis. 
As a first step to help identify causal variants at the nine SNP loci, we interrogated the 
ExomeChip data for putatively functional coding variants within genes harbouring or closest 
to the GWA SNPs. For the GREB1 locus, we found another coding variant rs10929757 
showing nominally significant association (P = 0.015) with endometriosis. The effect size of 
rs10929757 was similar (OR = 1.18) to the GWA SNP rs13394619 although they are poorly 
correlated (r2 = 0.25). Similarly, we also observed nominally significant association (P < 
0.018) for two coding variants (rs2383207 and rs4977574) in CDKN2B-AS1 - the closest 
gene to the GWA SNP rs1537377 at 9p21.3. Despite lack of correlation (r2 = 0.011 and 
0.005, respectively) with rs1537377, the effect sizes for both variants were similar (ORs = 
1.17 and 1.19, respectively). While these data may suggest independent association signals at 
GREB1 and 9p21.3 loci, the three coding variants need to be further investigated in larger 
sample size for a more conclusive interpretation. We did not observe evidence of association 
for other coding variants at nominal P < 0.05 even though the effect sizes for some were 
comparable to the GWA SNPs at each risk loci (data not shown). We did not detect any rare 
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coding variants at the GWA loci in spite from the ExomeChip data. This may, in part, be due 
to the reduced power in the Belgian sample to detect such rare variants. Assuming a disease 
prevalence of 8%, our sample size only had 45% power to detect alleles of frequency 0.20 
contributing to genotype relative risk of 1.15 (Purcell et al., 2003). As such, larger 
ExomeChip studies may be required to adequately investigate potential role of the 
coding/rare variants in risk of endometriosis and other complex traits. We cannot rule out the 
possibility of other types of rare functional variants at these loci - that are not adequately 
captured by either ExomeChip or current imputation methods - contributing to increased risk 
of endometriosis. These issues may be addressed by future studies utilizing larger sample 
sizes coupled with re-sequencing and further fine-mapping required to identify causal 
variants within the implicated GWA loci. Furthermore, controls used in this study are clinic-
based endometriosis-free individuals who presented with symptoms of subfertility. As such, 
they may have different allele frequencies compared to 'population-based' controls used in the 
most GWA studies and hence caution should be used in interpreting these results. 
Overall, results from the current replication study provide further supporting evidence 
for associations of the implicated SNP loci with endometriosis. Meta-analysis for these loci 
after including additional published results produced genome-wide significant evidence for 
the six loci, with similar magnitudes and directions of effect across studies and hence 
provided further evidence against any possibility of inflated genetic effects due to the 
winner's curse bias in the original study. More importantly, all the nine SNPs showed larger 
effect sizes with stage III/IV endometriosis than all cases, corroborating our previous 
observation for greater genetic loading in moderate-to-severe endometriosis.  
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